TTK Healthcare Limited has informed the Exchange regarding ''.
TTKHLTCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
TTK Healthcare's Executive Chairman Mr. T T Raghunathan shared the company's FY25 performance and FY26 plans at the 67th AGM. Revenue from Operations grew 6% to Rs.801.49 crores, while Pre-tax Profit rose sharply to Rs.108.33 crores (from Rs.84.12 crores), aided by a one-time Rs.19.77 crore gain on sale of leasehold land. EPS improved to Rs.57.79 from Rs.44.47, and the company sits on a strong free cash balance of around Rs.900 crores. Business-wise, Animal Welfare (up ~9%), Protective Devices (up ~9%), Foods (up ~8%) and Ortho (up ~18%) performed well, while Consumer Products was flat, hit by a sharp drop in Woodward's Gripe Water volumes. The board recommended a 100% dividend of Rs.10 per share, same as last year. The outlook for FY26 is described as positive overall, though the USAID stop-work order is flagged as a risk to the Protective Devices division.
Shareholders get steady returns with a consistent Rs.10 per share dividend and a robust Rs.900 crore cash pile that supports growth or capital returns. However, near-term sentiment may be tempered by the USAID order cancellation hurting the Protective Devices division's profitability and the discontinuation of PTCA Catheters due to weak market acceptance.